Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

CTIC
CTI BioPharma Corp. (DE) Common Stock
stock NASDAQ

Inactive
Jun 23, 2023
9.09USD0.000%(0.00)11,420,980
Pre-market
0.00USD-100.000%(-9.09)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsMore
open chart   
CEO
Adam Craig
Headquarters
Seattle, Washington, USA
Industry
Biotechnology
Last Split
Jan 3, 20171for10reverse
Related
AMGNINCYCELGNVSBAXBMYLLYTEVAMDGLXLV
Profile
cti was founded on the belief that a coalition between unique scientific technology and its strong desire to "do right" by the patient could help us achieve our mission to acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer. we strive to do business better than other biopharmaceutical companies. better means a more collaborative, well-trained team environment willing to institute novel approaches to scientific discovery and business opportunities. a willingness to push the limits to achieve challenging goals is the essential attribute that sets cti employees apart.


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC